1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

This listing may be outdated. Verify details at the official source before applying.

Find similar grants

ActiveNIH National Heart, Lung, and Blood Institute (NHLBI) · 2026

Vascular Biology and Hypertension

Quick Facts

Agency: NIH National Heart, Lung, and Blood Institute (NHLBI)
Funding: Varies
Deadline: Check Source
Status: Active
Eligibility: Academic institutions, non-profit organizations, and other eligible entities conducting biomedical research.

About This Grant

Vascular Biology and Hypertension is sponsored by NIH National Heart, Lung, and Blood Institute (NHLBI). This program focuses on the etiology, pathogenesis, prevention, diagnosis, and treatment of hypertension and vascular diseases, including vascular stiffness.

View Original RFP

Get a weekly digest of new grants like this

A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.

Or search similar grants →

Official Opportunity Details

Extracted from the official opportunity page/RFP to help you evaluate fit faster.

Latest Funding Opportunity Announcements (FOAs) NIH Announces the Open Period of FY 2027 Helium-3 Requests for Medical Research HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed) Looking for a contact in your research area?

Select a topic within the sections below to find a program officer and funding related to that topic.

Research Opportunity Announcement (ROA) OTA-21-015I: RECOVER PASC IMMUNOPHENOTYPING CORE LABORATORIES Research Opportunity Announcement (ROA) for Clinical Trials for the Prevention and/or Treatment of Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Notice of Intent to Publish a Research Opportunity Announcement (ROA) for Clinical Trials for the Prevention and/or Treatment of Post-Acute Sequelae of SARS CoV2 infection (PASC) (ROA): Observational Studies of COVID-19 – A Cohort of Cohorts OTA-2-011A Advanced Technologies and Surgery Adult and Pediatric Cardiac Research Atherothrombosis and Coronary Artery Disease Basic and Early Translational Research Clinical Applications and Prevention Global Cardiovascular Research Heart Failure & Arrhythmias Heart Development & Structural Diseases Heart Failure Data Challenge Office of Clinical Research Prevention and Population Sciences Vascular Biology and Hypertension Acute Lung Injury/Critical Care Chronic Obstructive Pulmonary Disease (COPD)/Environment Genetics, Genomics, and Advanced Technologies Interstitial Lung Disease/Fibrosis Lung Developmental Biology/Neonatal and Pediatric Diseases Lung Response to Pulmonary Infections, Microbiome, AIDS and Tuberculosis Sleep Science and Sleep Disorders Blood Epidemiology and Clinical Therapeutics Molecular Cellular and Systems Blood Science Translational Blood Science and Resources Sleep Science and Sleep Disorders Implementation Science Research Health Inequities and Global Health Precision Medicine Activities (TOPMed) (ROA): BioData Catalyst Data Management Core Program OTA-21-018 Clinical Trials Optimization Clinical Trials Optimization (Early Phase, Multi-Site, Single-Site, Late Phase) Global Cardiovascular Research

Eligibility Requirements

Academic institutions, non-profit organizations, and other eligible entities conducting biomedical research.

Frequently Asked Questions

Who can apply for Vascular Biology and Hypertension?

According to the current listing, eligibility includes: Academic institutions, non-profit organizations, and other eligible entities conducting biomedical research. Confirm the full requirements in the official notice before applying.

Who funds Vascular Biology and Hypertension?

Vascular Biology and Hypertension is funded by NIH National Heart, Lung, and Blood Institute (NHLBI). Verify program details on the funder's official page before applying.

How do I apply for Vascular Biology and Hypertension?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

NIH National Heart, Lung, and Blood Institute (NHLBI) Grant Writing Tips

NHLBI's Catalyze Program Will Fund Your Device Prototype Without Making You Start a Company — But It Wants Someone Else's Money First

Five NHLBI Catalyze Product Definition RFAs — HL-26-016 through HL-26-020 — carry an October 21, 2026 receipt date, budget caps of $300,000 to $400,000 per year, and roughly 8 new awards annually. The science is not the gate. An Accelerator Partner and a 0.25:1 non-federal cost match are, and both take longer to line up than the nine weeks you have left.

Read article

NIH's New F99/K00 Parent Award Pays for Five Years and Requires You to Leave Your University to Collect the Last Three

PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.

Read article

The White House Drafted a Veto Committee for NIH Grants. It Died in Four Days — and Section 157 Is Why.

A draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.

Read article